South Texas Blood & Tissue Center entered the exciting field of regenerative medicine with its formation of GenCure. This new service will focus on providing cell and tissue services for regenerative medicine, including patient treatment and clinical research on a global basis.
GenCure encompasses the bone marrow donor registration, tissue services, peripheral blood and cord blood cellular therapy programs. STBTC is pleased to continue its life saving mission and explore new opportunities in the future with regenerative medicine nationally and internationally.
GenCure will provide an opportunity to take advantage of new technologies and state-of-the-art processing and testing methods based on our existing foundation in tissue and cell work and move into this wonderful new field – providing growth opportunity and establishing STBTC as a major player in regenerative medicine.
GenCure has ongoing research collaborations with Scripps Research Institute, the National Disease Research Interchange (NDRI), Cytonet, University of Texas Health Science Center, University of Illinois and Lonza Walkersville, Inc. GenCure's advisors include experts from the University of Pittsburgh, University of Illinois, University of Texas Health Science Center at San Antonio, University of South Florida College of Medicine, and Georgia Tech.
GenCure services are accredited by the American Association of Blood Banks, American Association of Tissue Banks, the International Organization of Standardization, and where applicable, states requiring HCT state licensure and regulated by the Food and Drug Administration.
The three existing entities – Texas Cord Blood Bank, Marrow Donor Program of South and Central Texas, and Tissue Services – will continue in their traditional life saving modes, while at the same time moving towards the next level of scientific advancements in the field of regenerative medicine.